ARCHIVES

Amgen, J&J Defend ESA Indications.

This article is from The Cancer Letter archive.

Vol. 34 No. 11 | March 21, 2008

Download PDF Visit The Full Archive

Related Articles

Stimulus Bill Gives NIH A $10 Billion Boost Over Two Years, Puts Pressure On Institutes to Make Rapid Funding Decisions

February 13, 2009

NCI Gets Withheld Funds; Hazleton Tops List In Stepped-Up Award Flow

April 4, 1975

Drugs and Targets: Cyramza approved in metastatic stomach cancer

November 7, 2014

Raymond Weiss Reviews Confidential Report on I-ELCAP

April 29, 2011

NCI Programs: U.S., U.K., Ireland Established Consortium For Cancer Research

October 15, 1999

Longer List of DCPC Spending Plans $40 Mll Increase

December 10, 1993